Autopsy report · NCT03997474

ATL001 in Patients With Metastatic or Recurrent Melanoma

Cause of deathFunding or business Automatic label, confidence 0.9, unverified. How labels are made.

“Sponsor decision”

The sponsor’s own words in the registry.

Life of this trial

Registered 6 months before it started.
Ran for about 5 years 1 month before it stopped.
13 participants enrolled.
Results were posted on the registry 6 months after it ended.

Vital statistics

Status: Terminated
Phase: Phase 1, Phase 2
Sponsor: Achilles Therapeutics UK Limited
Sponsor type: Industry
Conditions: Melanoma
Interventions: ATL001; Checkpoint Inhibitor
Participants: 13
Sites: 10
Countries: Spain, United Kingdom

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.